Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364748
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-03-05
Brief Title:
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
Sponsor:
West Michigan Cancer Center
Organization:
West Michigan Cancer Center
Study Overview
Official Title:
Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer
Status:
RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized trial of remote blood pressure monitoring compared to usual care in patients receiving bevacizumab to determine whether remote blood pressure monitoring improves the collection of blood pressure data identification and management of clinically significant hypertension and patient satisfaction
Detailed Description:
Remote patient monitoring RPM technology has the potential to improve the early detection and management of clinically significant hypertension in cancer patients undergoing therapy with bevacizumab by allowing immediate communication of abnormal measurements to the clinical care team Additionally RPM may decrease patients and caregivers burdens of ongoing cancer care through an improved user experience compared to usual care
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
True
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None